(Q38055659)

27 August 2017

0 references

Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis (English)

1 reference

27 August 2017

0 references

congestive heart failure

1 reference

1 reference

Sebhat Erqou

1

1 reference

27 August 2017

Chee-Tin Christine Lee

2

1 reference

27 August 2017

Matthew Suffoletto

3

1 reference

27 August 2017

Justin B Echouffo-Tcheugui

4

1 reference

27 August 2017

Rudolf A de Boer

5

1 reference

27 August 2017

Joost P van Melle

6

1 reference

27 August 2017

Amanda I Adler

7

1 reference

27 August 2017

25 October 2012

1 reference

European Journal of Heart Failure

27 August 2017

1 reference

27 August 2017

15

1 reference

27 August 2017

2

1 reference

27 August 2017

185-193

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

27 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Heart failure: a global disease requiring a global response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Glycemic status and incident heart failure in elderly without history of diabetes mellitus: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Glycemic control and heart failure among adult patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Insulin resistance and risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

The cardioprotective effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Controversies in the cardiovascular management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS156

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-141-6-200409210-00007

Identifiers

DOI

10.1093/EURJHF/HFS156

1 reference

27 August 2017

1 reference